Changes in peak oxygen consumption in Fabry disease and associations with cardiomyopathy severity
Roy, Ashwin Thompson, Sophie E Hodson, James van Vliet, Jan Condon, Nicola Alvior, Amor Mia O'Shea, Christopher Vijapurapu, Ravi Nightingale, Tom E Clift, Paul F
Roy, Ashwin
Thompson, Sophie E
Hodson, James
van Vliet, Jan
Condon, Nicola
Alvior, Amor Mia
O'Shea, Christopher
Vijapurapu, Ravi
Nightingale, Tom E
Clift, Paul F
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2024-11-25
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
This was a retrospective observational study of adults with FD undergoing cardiopulmonary exercise testing (CPEX) between September 2011 and September 2023 at a national referral centre in the UK. The primary outcome measure was peak oxygen uptake (V̇O2peak), with forced expiratory volume in 1 s (FEV1) used to quantify respiratory impairment. Age-normalised/sex-normalised values were additionally calculated, based on published normal ranges for subgroups of age and sex. The cardiomyopathy phase was classified on a 4-point scale by two FD experts using contemporaneous imaging and biochemistry results.
Citation
Roy A, Thompson SE, Hodson J, van Vliet J, Condon N, Alvior AM, O'Shea C, Vijapurapu R, Nightingale TE, Clift PF, Townend J, Geberhiwot T, Steeds RP. Changes in peak oxygen consumption in Fabry disease and associations with cardiomyopathy severity. Heart. 2024 Nov 25:heartjnl-2024-324553. doi: 10.1136/heartjnl-2024-324553. Epub ahead of print.
Type
Article